当前位置: 首页 > 期刊 > 《新医学》 > 20197
编号:13543035
SDX抑制NLRP3炎症小体激活以减轻糖尿病视网膜微血管渗漏(5)
http://www.100md.com 2019年7月1日 《新医学》 20197
     [17] 王琪,周丽,李静仁,朱碧连,唐喜香,陈燕铭. 活化转录因子4参与高糖诱导的人视网膜微血管内皮细胞炎症. 新医学, 2017, 48(7): 455-460.

    [18] Li Y, Zhou ZH, Chen MH, Yang J, Leng J, Cao GS, Xin GZ, Liu LF, Kou JP, Liu BL, Li P, Wen XD. Inhibition of mitochondrial fission and nox2 expression prevent NLRP3 inflammasome activation in the endothelium: the role of corosolic acid action in the amelioration of endothelial dysfunction. Antioxid Redox Signal, 2016, 24(16): 893-908.

    [19] Chen Y, Wang L, Pitzer AL, Li X, Li PL, Zhang Y. Contri-bution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfun-ction. J Mol Med (Berl), 2016, 94(12): 1335-1347.

    [20] Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, Da PA, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood, 2013, 122(20): 3405-3414.

    [21] Giurdanella G, Lazzara F, Caporarello N, Lupo G, Anfuso CD, Eandi CM, Leggio GM, Drago F, Bucolo C, Salomone S. Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE. Biochem Pharmacol, 2017, 142: 145-154.

    (收稿日期:2019-04-29)

    (本文編辑:洪悦民), 百拇医药(李静仁?李婷?何学敏?周丽?唐喜香?陈燕铭)
上一页1 2 3 4 5